Responsiveness of the adult male rat reproductive tract to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: Ah receptor and ARNT expression, CYP1A1 induction, and Ah receptor down-regulation

Toxicology and Applied Pharmacology

Volumn 150, Issue 2, 1998, Pages 228-239

  Roman, Beth L ^a   Pollenz, Richard S ^b   Peterson, Richard E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARRIER PROTEIN; ETHOXYRESORUFIN DEETHYLASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; EPIDIDYMIS; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; GERM CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MALE GENITAL SYSTEM; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTATE VENTRAL LOBE; RAT; RECEPTOR DOWN REGULATION; SEMINAL VESICLE; SMOOTH MUSCLE FIBER; TESTIS; VAS DEFERENS;

ANIMALIA;

EID: 0010417886     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8388     Document Type: Article

References (64)

1. Abbott B. D., Perdew G. H., Buckalew A. R., Birnbaum L. S. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 128:1994a;138-150.
2. Abbott B. D., Probst M. R. Developmental expression of two members of a new class of transcription factors. II. Expression of aryl hydrocarbon receptor nuclear translocator in the C57BL/6N mouse embryo. Dev. Dyn. 204:1995;144-155.
3. Abbott B. D., Probst M. R., Perdew G. H. Immunohistochemical double staining for Ah receptor and ARNT in human embryonic palatal shelves. Teratology. 50:1994b;361-366.
4. Abnet C. C., Peterson R. E. Regulation of aryl hydrocarbon receptor (AhR) mRNA abundance by 2,3,7,8-tetrachlorodibenzo-p. Fundam. Appl. Toxicol. Suppl. 36:1997;128.
5. Alexander I. E., Clarke C. L., Shine J., Sutherland R. L. Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Mol. Endocrinol. 3:1989;1377-1386.
6. Carlstedt-Duke J. M. B. Tissue distribution of the receptor for 2,3,7,8-tetrachlorodibenzo-p. Cancer Res. 39:1979;3172-3176.
7. Carver L. A., Hogenesch J. B., Bradfield C. A. Tissue specific expression of the rat Ah-receptor and ARNT mRNAs. Nucleic Acids Res. 22:1994;3038-3044.
8. Chen S.-W., Roman B. L, Saroya S. Z., Shinomiya K., Moore R. W., Peterson R. E. In uterop. Toxicologist. 13:1993;104.
9. Christou M., Savas U., Schroeder S., Shen X., Thompson T., Gould M. N., Jefcoate C. R. Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: Cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol. Cell. Endocrinol. 115:1995;41-50.
10. Dong Y., Poellinger L., Gustafsson J.-Å, Okret S. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms. Mol. Endocrinol. 2:1988;1256-1264.
11. Eguchi H., Ikuta T., Tachibana T., Yoneda Y., Kawajiri K. A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1β is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J. Biol. Chem. 272:1997;17640-17647.
12. Ema M., Taya S., Yokotani N., Sogawa K., Matsuda Y., Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. USA. 94:1997;4273-4278.
13. Enan E., Matsumura F. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p. Biochem. Pharmacol. 49:1995;249-261.
14. Fernandez-Salguero P. M., Hilbert D. M., Rudikoff S., Ward J. M., Gonzalez F. J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 140:1996;173-179.
15. Fernandez-Salguero P., Pineau T., Hilbert D. M., McPhail T., Lee S. S. T., Kimura S., Nebert D. W., Rudikoff S., Ward J. M., Gonzalez F. J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science. 268:1995;722-726.
16. Forsythe J. A., Jiang B.-H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16:1996;4604-4613.
17. Gasiewicz T. A., Rucci G. Cytosolic receptor for 2,3,7,8-tetrachlorodibenzo-p. Mol. Pharmacol. 26:1984;90-98.
18. Germolec D. R., Henry E. C., Maronpot R., Foley J. F., Adams N. H., Gasiewicz T. A., Luster M. I. Induction of CYP1A1 and ALDH-3 in lymphoid tissues from Fisher 344 rats exposed to 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 137:1996;57-66.
19. Giannone J. V., Okey A. B., Harper P. A. Characterization of polyclonal antibodies to the aromatic hydrocarbon receptor. Can. J. Physiol. Pharmacol. 73:1995;7-17.
20. Haaparanta T., Glaumann H., Gustaffson J.-Å. Induction of cytochrome P-450 dependent reactions in the rat ventral prostate by β-naphthoflavone and 2,3,7,8-tetrachlorodibenzo-p. Toxicology. 29:1983a;61-75.
21. Haaparanta T., Halpert J., Glaumann H., Gustafsson J.-Å. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate. Cancer Res. 43:1983b;5131-5137.
22. Haaparanta T., Norgård M., Haglund L., Glaumann H., Gustafsson J.-Å. Immunohistochemical localization of cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate. Cancer Res. 45:1985;1259-1262.
23. Henry E. C., Rucci G., Gasiewicz T. A. Characterization of multiple forms of the Ah receptor: Comparison of species and tissues. Biochemistry. 28:1989;6430-6440.
24. Hess R. A. Quantitative and qualitative characteristics of the stages and transitions in the cycle of the rat seminiferous epithelium: Light microscopic observations of perfusion-fixed and plastic-embedded testes. Biol. Reprod. 43:1990;525-542.
25. Hogenesch J. B., Cahn W. K., Jackiw V. H., Brown R. C., Gu Y.-Z., Pray-Grant M., Perdew G. H., Bradfield C. A. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J. Biol. Chem. 272:1997;8581-8593.
26. Holmes J. L., Pollenz R. S. Determination of aryl hydrocarbon receptor nuclear translocator protein concentration and subcellular localization in hepatic and nonhepatic cell culture lines: Development of quantitative Western blotting protocols for calculation of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein in total cell lysates. Mol. Pharmacol. 52:1997;202-211.
27. Hord N. G., Perdew G. H. Physicochemical and immunocytochemical analysis of the aryl hydrocarbon receptor nuclear translocator: Characterization of two monoclonal antibodies to the aryl hydrocarbon receptor nuclear translocator. Mol. Pharmacol. 46:1994;618-626.
28. Johnson L., Dickerson R., Safe S. H., Nyberg C. L., Lewis R. P., Welsh T. H. Reduced Leydig cell volume and function in adult rats exposed to 2,3,7,8-tetrachlorodibenzo-p. Toxicology. 76:1992;103-118.
29. Johnson L., Wilker C. E., Safe S. H., Scott B., Dean D. D., White P. H. 2,3,7,8-Tetrachlorodibenzo-p. Toxicology. 89:1994;49-65.
30. Khera K. S., Ruddick J. A. Polychlorodibenzo-p. Chlorodioxins: Origin and Fate. 1973;American Chemical Society, Washington. p. 70-84.
31. Kleeman J. M., Moore R. W., Peterson R. E. Inhibition of testicular steroidogenesis in 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 106:1990;112-125.
32. Kluwe W. M., Hook J. B. Comparative induction of xenobiotic metabolism in rodent kidney, testis and liver by commercial mixtures of polybrominated biphenyls and polychlorinated biphenyls, phenobarbital and 3-methylcholanthrene: Absolute and temporal effects. Toxicology. 20:1981;259-273.
33. Lee I. P., Suzuki K. Induction of aryl hydrocarbon hydroxylase activity in the rat prostate glands by 2,3,7,8-tetrachlorodibenzo-p. J. Pharmacol. Exp. Ther. 215:1980;601-605.
34. Mably T. A., Bjerke D. L., Moore R. W., Gendron-Fitzpatrick A., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 114:1992a;118-126.
35. Mably T. A., Moore R. W., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 114:1992b;97-107.
36. Matsuda T., Imaoka S., Funae Y., Otori K., Fukushima S. Induction of CYP isoenzymes in various organs of rats by 3-methylcholanthrene or β-naphthoflavone. Cancer Lett. 97:1995;137-143.
37. Matsumura F., Enan E., Dunlap D. Y., Pinkerton K. E., Peake J. Alteredin vivop. Biochem. Pharmacol. 53:1997;1397-1404.
38. Mattison D. R., Thorgeirsson S. S. Gonadal aryl hydrocarbon hydroxylase in rats and mice. Cancer Res. 38:1978;1368-1373.
39. Mebus C. A., Reddy V. R., Piper W. N. Depression of rat testicular 17-hydroxylase and 17,20-lyase after administration of 2,3,7,8-tetrachlorodibenzo-p. Biochem. Pharmacol. 36:1987;727-731.
40. SCC. Toxicol. Appl. Pharmacol. 109:1991;85-97.
41. Moore R. W., Peterson R. E. Androgen catabolism and excretion in 2,3,7,8-tetrachlorodibenzo-p. Biochem. Pharmacol. 37:1988;560-562.
42. Moore R. W., Potter C. L., Theobald H. M., Robinson J. A., Peterson R. E. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 79:1985;99-111.
43. Omiecinski C. J., Redlich C. A., Costa P. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction. Cancer Res. 50:1990;4315-4321.
44. Poland A., Glover E. 2,3,7,8-tetrachlorodibenzo-p. Mol. Pharmacol. 17:1980;86-94.
45. Poland A., Glover E. Variation in the molecular mass of the Ah receptor among vertebrate species and strains of rats. Biochem. Biophys. Res. Commun. 146:1987;1439-1449.
46. Poland A., Knutson J. C. 2,3,7,8-Tetrachlorodibenzo-p. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
47. Pollenz R. S. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p. Mol. Pharmacol. 49:1996;391-398.
48. Pollenz R. S., Santostefano M. J., Klett E., Richardson V. M., Necela B., Birnbaum L. S. Female Sprague-Dawley rats exposed to a single oral dose of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Sci. 42:1998.
49. Pollenz R. S., Sattler C. A., Poland A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol. 45:1994;428-438.
50. Probst M. R., Fan C.-M., Tessier-Lavigne M., Hankinson O. Two murine homologs of theDrosophila. J. Biol. Chem. 272:1997;4451-4457.
51. Roman B. L., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 150:1998;240-253.
52. Roman B. L., Sommer R. J., Shinomiya K., Peterson R. E. In uterop. Toxicol. Appl. Pharmacol. 134:1995;241-250.
53. Rune G. M., de Souza Ph., Krowkw R., Merker H. J., Neubert D. Morphological and histochemical pattern of response in rat testes after administration of 2,3,7,8-tetrachlorodibenzo-p. Histol. Histopathol. 6:1991;459-467.
54. Saceda M., Lippman M. E., Chambon P., Lindsey R. L., Ponglikitmongkol M., Puente M., Martin M. B. Regulation of estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2:1988;1157-1162.
55. Schmidt J. V., Bradfield C. A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:1996;55-89.
56. Schmidt J. V., Su G.H.-T., Reddy J. K., Simon M. C., Bradfield C. A. Characterization of a murineAhr. Proc. Natl. Acad. Sci. USA. 93:1996;6731-6736.
57. Söderkvist P., Poellinger L., Gustafsson J.-Å. Carcinogen-binding proteins in the rat ventral prostate: Specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p. Cancer Res. 46:1986;651-657.
58. Söderkvist P., Poellinger L., Toftgård R., Gustafsson J.-Å. Differential expression of the cytochrome P-450c and P-450d genes in the rat ventral prostate. Cancer Res. 48:1988;3045-3049.
59. Söderkvist P., Toftgård R., Gustafsson J.-Å. Induction of cytochrome P-450 related metabolic activities in the rat ventral prostate. Toxicol. Lett. 10:1982;61-69.
60. Sutter T. R., Greenlee W. F. Classification of members of the Ah gene battery. Chemosphere. 25:1992;223-226.
61. Swanson H. I., Perdew G. H. Half-life of the aryl hydrocarbon receptor in Hepa-1 cells. Arch. Biochem. Biophys. 302:1993;167-174.
62. Swanson H. I., Chan W. K., Bradfield C. A. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J. Biol. Chem. 270:1995;26292-26302.
63. Tian H., McKnight S. L., Russell D. W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:1997;72-82.
64. 2. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.